Clinical Trials

159 enrolled

Colorectal Neoplasms

NCT03078348 2022-11-09

IACCT

331 enrolled

Colorectal Neoplasms

NCT00373217 2022-09-21

Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Phase 2 Terminated

6 enrolled 9 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01804179 2022-09-10

Colorectal Cancer Awareness, Research, Education and Screening (CARES)

514 enrolled

Neoplasms, Colorectal Neoplasms

NCT03041701 2022-04-14

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

14 enrolled 17 charts

Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT04275960 2020-12-29

Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body

Phase EARLY_PHASE1 Terminated

24 enrolled

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Phase 2 Completed

275 enrolled 23 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00091286 2020-03-30

Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer

11 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00681993 2019-01-22

PBIC

35 enrolled

Breast

Breast Neoplasms

NCT01753713 2017-12-12

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Completed

33 enrolled 14 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00555724 2017-01-09

Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors

40 enrolled

Recurrence

NCT01515969 2016-07-12

Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Terminated

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT01588301 2014-09-12

APACHE-2

5,998 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00956436 2013-09-16

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

40 enrolled

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00970580 2013-09-16

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

18 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00633724 2013-08-15

Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT00874588 2013-08-15

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

6 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00632333 2011-07-21

Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

Phase 1 Unknown

Esophageal Neoplasms

NCT01266707 2010-12-24

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Phase 1 Unknown

Carcinoma, Hepatocellular

NCT01266720 2010-12-24

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Phase 1 Unknown

6 enrolled

Pancreatic Neoplasms

NCT00677287 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00677326 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

1 enrolled

Breast

Breast Neoplasms

NCT00677612 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00681252 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Stomach Neoplasms

NCT00681421 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Phase 1/2 Completed

Esophageal Neoplasms

NCT00681577 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Stomach Neoplasms

NCT00683358 2009-05-07

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Phase 1/2 Unknown

Neoplasms, Pancreatic Neoplasms

NCT00561275 2008-07-15

Safety Study of Multiple Peptide Vaccine to Esophageal Cancer

6 enrolled

Esophageal Neoplasms

NCT00673777 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Phase 1/2 Unknown